The Ballast.

Consumer staples and defensives — what we're working on. The chips that carried the index have started to come down, and even a blockbuster quarter from Micron couldn't hold the line.

Six weeks ago, in The Other 493, we argued that a tape held up by eight or ten semiconductor names was a basket trade with a benchmark stapled to it — and that the resolution, when it came, would not be a crash in the index but a rotation underneath it. This week, the rotation arrived with force. The semiconductor complex had its worst stretch of the year. Defensives held. And the cleanest illustration of the whole regime change was a company that did everything right.

On Wednesday after the close, Micron reported what is, by any measure, a blockbuster quarter. Fiscal third-quarter revenue of $41.5 billion against a $35.7 billion consensus — a number that roughly quadrupled from $9 billion a year earlier, driven by high-bandwidth memory that is sold out for the year. Adjusted earnings of $25.11 a share blew past the $20.49 the Street expected. The stock leapt as much as fifteen percent. And then, by Friday's bell, it had given it all back and more. Micron ended the week lower. There is no cleaner signal in markets right now.

01 / The signalWhen good news stops working.

The most important thing a market can do is tell you what it no longer cares about. For two years, a beat-and-raise from a memory or AI-infrastructure name was an automatic bid — not just for the company, but for the entire index that leans on it. This week that reflex broke. Micron printed a genuinely exceptional quarter and the stock could not hold a gain into the weekly close. When a blowout is met with selling, the issue is not the earnings. It is the price already paid for them, and the positioning stacked on top.

The proximate trigger was Broadcom. Hock Tan, on the prior week's call, declined to raise the full-year AI semiconductor target — and a sector priced for permanent acceleration read a merely-very-good outlook as a top. The iShares Semiconductor ETF fell about ten percent on Friday, its sharpest day since March 2020, and the chip cohort shed roughly a trillion dollars of market value on the week. Micron, which was not the cause of any of it, fell harder than almost all of its peers. The names that climb fastest give back the most when the marginal buyer steps away.

A company can report the best quarter in its history and still end the week red. That is not a verdict on the company. It is a verdict on the crowd that owned it.

02 / The other side of the tradeWhere the money went.

Capital did not leave the market this week. It moved. As the AI complex unwound, the defensive corners of the index did exactly what they are supposed to do in a regime shift — they absorbed the flow and held the tape together. Since the early-June peak, consumer staples have been the strongest sector in the S&P, up around 3.8%, with real estate and healthcare close behind while the high-flyers bled. Coca-Cola, Colgate-Palmolive, the steady compounders that sell things people buy whether the cycle is hot or cold — these caught the bid.

This is the part of the market we have been building toward, and it is the part we want to spend this note on. Staples and defensives are not exciting. They will never quadruple revenue in a year. What they offer is the one thing a portfolio leaning on a single crowded theme does not have: earnings that show up regardless of the macro weather. Demand for toothpaste, packaged food, household goods, and electricity does not depend on whether hyperscaler capex plateaus in 2027. That insensitivity is the entire point. It is ballast — the weight low in the hull that keeps the boat upright when the wind shifts.

03 / The honest caveatDefensive is not the same as cheap.

We will not pretend the defensive trade is a free lunch. Staples ran hard earlier this year — the sector was up roughly fifteen percent into the spring as the first wave of tech anxiety pushed money into safety — and that means part of the valuation cushion has already been spent. Utilities, the other classic defensive, have started to underperform after a long run that lifted both their multiples and their earnings expectations. Buying defensives after they have rerated is a different proposition from buying them before.

So our work here is selective, not wholesale. We are not buying the staples index. We are underwriting individual names with pricing power that outruns input costs, balance sheets that fund their own dividends, and valuations that have not yet fully repriced to reflect their newfound popularity. The goal is the durable cash flow, bought at a sensible multiple — not the label. A defensive stock purchased at an indefensible price is just a slow way to lose money.

04 / PositioningWhat we are doing.

Last month we said we were adjusting weights, not making a heroic call. The same discipline applies, one rotation further along.

• Adding to a core of consumer-staples and defensive compounders — packaged food, household and personal care, beverages, and selective healthcare — chosen for pricing power and dividend durability rather than for the sector label. Sized to be ballast, not a bet.
• Trimming the tactical semiconductor shorts we put on in May into this week's drawdown. The thesis played out faster than expected; we are taking the gain rather than pressing a crowded short after a trillion-dollar repricing.
• Avoiding the parts of the defensive trade that have already rerated hardest — notably stretched utilities — where the safety is real but the price no longer is.
• Holding ample cash. If the chip unwind has a second leg, the best defensive names will go on sale alongside everything else, and dry powder is what turns a selloff into an entry.

The lesson of the week is compact enough to keep: Micron did everything a company can do and still finished red, while a tube of toothpaste outperformed a memory chip. That is what the late innings of a crowded theme look like. We are not calling the top of the AI cycle — the earnings are real and the secular story stands. We are building the part of the book that does not need that story to be right. When the leadership of a market narrows to a handful of names, the smartest position is often the one that can sit out the next argument entirely.

This note reflects the views of AMA Invest as of the publication date and is provided for informational purposes only. It does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product, nor investment advice. Company names are referenced for illustration only and are not recommendations to buy or sell any security. Statements regarding markets, positioning, and outlook are the manager's opinions and are subject to change without notice. Forward-looking statements involve risk and uncertainty; actual results may differ materially. Past performance is not indicative of future results. Investments in the fund are available only to eligible investors who meet applicable suitability and accreditation requirements under relevant jurisdictions. All investments involve risk, including the possible loss of principal.